Collections

Filters ​

  • Special |

    To fully understand human health and allow everyone access to advances in biomedicine, research programmes must include participants from diverse backgrounds. Nature marked its 150th anniversary in 2018 by introducing a weekly photo essay profiling a scientist in their workplace. Since then, the Where I Work section has showcased more than 200 scientists from more than 70 countries at work in labs, during fieldwork, running companies, funding agencies, treating patients and teaching children. The photographs, now exhibited in King’s Cross, London, depict and celebrate the diversity of science and scientists.

    Image: Danielle Mastrion/All of Us Research Program

  • Collection |

    With this collection, Nature Communications, Nature Medicine, Communications Medicine and Scientific Reports aim to publish research articles spanning the breadth of AMR and across microbial pathogens (bacteria, viruses, fungi and parasites). This includes, and is not limited to epidemiological monitoring of resistance incidence in clinical and environmental settings, novel strategies aiming to combat or prevent AMR (i.e. drug repurposing, drug synergy treatment, and vaccines), improvements in diagnostics, and subsequently tailored treatment, of drug-resistant infections.

    Image: ©TopMicrobialStock / stock.adobe.com
    Open for submissions

  • Collection |

    With this Collection, a partnership between Nature, Nature Medicine and Nature Communications, we welcome submissions of primary research papers that focus on neo-adjuvant immunotherapies and related combinatorial approaches (such as radio-immunotherapy or chemo-immunotherapy).

    Image: wildpixel / Getty Images / iStock
    Open for submissions

  • Collection |

    Detailed method reporting is essential for research reproducibility and trust in published results.

    Image: Sam Whitham

  • Collection |

    The 2023 Nobel prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.

    Image: Springer Nature/The Nobel Foundation/Imagesource

  • Focus |

    Nature Medicine presents a special Focus dedicated to population health in the context of new threats and growing inequities.

    Image: Marina Spence

  • Collection |

    The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.

    Image: © Springer Nature
    Open for submissions

  • Collection |

    Stem cell models of development, regeneration, and disease are quickly advancing. New technologies and concepts are continuously combined with existing knowledge to create more realistic systems to improve our understanding of these intricate processes. In this collection, we highlight papers published in 2022-2023 across Nature Portfolio journals on topics including embryonic development and stem cells, reproductive biology, synthetic tissues and embryo models, clinical and translational research and tissue stem cells.

    Image: Jean-Baptiste Sibarita, Virgile Viasnoff, and Anne Beghin

  • Collection |

    Cancer is a leading cause of death, accounting for nearly one in six deaths worldwide. Many cancers can be cured, especially if detected early and treated effectively.

    Image: Kateryna Lon/ Science Photo Library/ Getty Images

  • Series |

    New therapeutics and health technologies require fresh approaches to demonstrating safety and efficacy.

    Image: Marina Spence

  • Special |

    It is the age of large biobanks in human genetics.

    Image: Federico Simeoni, Małgorzata Nowicka, Nicola Cerioli, Rupesh Vyas